This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shiou, S.-R. Articles by Dhawan, P. Search for Related Content PubMed PubMed Citation Articles by Shiou, S.-R. Articles by Dhawan, P.

Smad4 Regulates Claudin-1 Expression in a Transforming Growth Factor-ß–Independent Manner in Colon Cancer Cells

Surgical Oncology Research Laboratories, Departments of ¹ Surgery, ² Cancer Biology, ³ Cell and Developmental Biology, ⁴ Medicine and ⁵ Pathology, Vanderbilt University Medical Center, Nashville, Tennessee

Requests for reprints: Punita Dhawan, Division of Surgical Oncology, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232. Phone: 615-322-4755; Fax: 615-322-6174; E-mail: punita.dhawan{at}vanderbilt.edu or R. Daniel Beauchamp, Section of Surgical Sciences, Vanderbilt University Medical Center 1161, 21st Avenue South, D-4316 Nashville, TN 37232-2730. Phone: 615-322-2363; E-mail: dan.beauchamp{at}vanderbilt.edu.

We have recently reported that the expression of a tight junction protein, claudin-1, is increased during colon carcinogenesis and particularly metastatic colorectal cancer. Manipulation of claudin-1 levels in colon cancer cells showed a positive correlation between claudin-1 expression and tumor growth and metastasis. However, the mechanisms underlying the increased claudin-1 expression in colorectal cancer remains unknown. The tumor suppressor Smad4 is a central intracellular signal transduction component of the transforming growth factor-ß (TGF-ß) family of cytokines. Loss of Smad4 protein expression is correlated with poor prognosis and is frequently observed in invasive and metastatic colorectal carcinoma. In the present study, we report an inverse relationship between Smad4 and claudin-1 expression in human colorectal carcinoma tumor samples and in human colon cancer cell lines. We found that the expression of Smad4 in Smad4-deficient but claudin-1–positive SW480 or HT29 colon cancer cell lines down-regulates claudin-1 expression through transcriptional repression by modulating ß-catenin/T-cell factor/lymphocyte enhancer factor activity. Furthermore, this Smad4-dependent inhibition of claudin-1 expression is independent of TGF-ß signaling because Smad4 expression alone is insufficient to restore TGF-ß signaling in the SW480 cells, and the selective TGF-ß receptor kinase inhibitor LY364947 did not prevent the Smad4 suppression of claudin-1 protein expression in either SW480 or HT29 cells. Taken together, these findings suggest a novel mechanism underlying Smad4 tumor–suppressive function through regulation of a potential metastatic modulator, claudin-1, in a TGF-ß–independent manner. [Cancer Res 2007;67(4):1571–9]

This article has been cited by other articles:

				K. Zhang, H.-P. Yao, and M.-H. Wang Activation of RON differentially regulates claudin expression and localization: role of claudin-1 in RON-mediated epithelial cell motility Carcinogenesis, March 1, 2008; 29(3): 552 - 559. [Abstract] [Full Text] [PDF]